| Total (n=223) | With ocular involvements (n=118) | Without ocular involvements (n=104) | p value | |
|---|---|---|---|---|
| Gastrointestinal manifestations | 56/223 (25.1%) | 17/118 (14.4%) | 39/104 (37.5%) | <0.001 |
| Neurogenic diseases | 20/223 (9.0%) | 19/118 (16.1%) | 1/104 (1.0%) | <0.001 |
| Vascular involvements | 18/223 (8.1%) | 7/118 (5.9%) | 11/104 (10.6%) | 0.21 |
| HLA-B51 positive | 51/123 (41.5%) | 36/69 (52.2%) | 15/54 (27.8%) | 0.006 |
| HLA-A26 positive | 28/116 (24.1%) | 19/65 (29.2%) | 9/51 (17.6%) | 0.15 |